Literature DB >> 31657093

Diagnosis of mild cognitive impairment using multiple neuroimaging modalities in addition to the Mini-Mental State Examination.

Hiromi Kaneko1, Noriyuki Kimura1, Saho Nojima1, Kanako Abe1, Yasuhiro Aso1, Etsuro Matsubara1.   

Abstract

AIM: This prospective study investigated the additional utility of combining multiple imaging modalities with the Mini-Mental State Examination (MMSE) in discriminating individuals with mild cognitive impairment (MCI) from cognitively normal individuals.
METHODS: A total of 103 individuals with amnestic MCI and normal cognitive function were recruited from outpatients; they underwent examination using the MMSE, magnetic resonance imaging, 18 F-fluorodeoxyglucose positron emission tomography and 11 C-Pittsburgh compound B positron emission tomography. Binary logistic regression with receiver operator characteristic analysis was used to assess the combination of the abovementioned single or multiple imaging modalities with the MMSE. Eight models were constructed, and their area under the curve values and misclassification rates in discriminating individuals with amnestic MCI from cognitively normal individuals were evaluated.
RESULTS: The addition of each of the imaging modalities improved the discrimination accuracy over that of the MMSE alone; the accuracy obtained with the addition of 18 F-fluorodeoxyglucose positron emission tomography was the highest. The best model with the highest accuracy included a combination of all the imaging modalities in addition to the MMSE (area under the curve value 0.902).
CONCLUSIONS: The combination of all the imaging modalities in addition to the MMSE could facilitate more accurate diagnosis of amnestic MCI. Of the individual imaging modalities, the highest accuracy resulted from the addition of 18 F-fluorodeoxyglucose positron emission tomography to the MMSE. Geriatr Gerontol Int 2019; 19: 1193-1197.
© 2019 Japan Geriatrics Society.

Entities:  

Keywords:  11C-Pittsburgh compound B positron emission tomography; 18F-fluorodeoxyglucose positron emission tomography; magnetic resonance imaging; mild cognitive impairment

Mesh:

Year:  2019        PMID: 31657093     DOI: 10.1111/ggi.13789

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  2 in total

1.  Association between sarcopenia and cognitive impairment in community-dwelling population.

Authors:  Hui Zhu; Heng-Dong Li; Bei-Li Feng; Lu Zhang; Zai-Xing Zheng; Yue Zhang; Dong-Juan Wang; Zi Xiong; Jun-Fei Kang; Jia-Chang Jin; Jie Lin; Hong-Hua Ye
Journal:  Chin Med J (Engl)       Date:  2020-12-07       Impact factor: 2.628

2.  Increased Plasma Level of 24S-Hydroxycholesterol and Polymorphism of CYP46A1 SNP (rs754203) Are Associated With Mild Cognitive Impairment in Patients With Type 2 Diabetes.

Authors:  Jijing Shi; Jianhong Jia; Sai Tian; Haoqiang Zhang; Ke An; Wenwen Zhu; Wuyou Cao; Yang Yuan; Shaohua Wang
Journal:  Front Aging Neurosci       Date:  2021-05-13       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.